Advertisement intended for health care professionals

l

Iron-laden macrophage in autoimmune disease

Iron-laden macrophage in autoimmune disease
#00024624
Author: Rebecca L. King and Mitchell J. Weiss
Category: Red Cell: Disorders of Iron Metabolism and Heme Synthesis > Hemochromatosis
Published Date: 01/23/2014

A 14-year-old African American adolescent boy presented with a 20-lb weight loss, malaise, and arthralgia. Physical examination was unremarkable. CBC showed pancytopenia with a hemoglobin level of 7.9 g/dL, leukocytes 1.2 × 109/L, and platelets 137 × 109/L. Peripheral smear showed occasional dacrocytes and schistocytes. Other testing showed a creatinine level of 1.3 mg/dL, 1+ proteinurea, erythrocyte sedimentation rate of 99, iron level of 48 µg/dL, transferrin level of 114 mg/dL, and ferritin level of 1200 ng/mL. The bone marrow was mildly hypocellular, with erythroid hypoplasia, left-shifted granulopoiesis, and no evidence of malignancy. A bone marrow core biopsy was stained with (panel A) hematoxylin and eosin or (panel B) Prussian blue, indicating iron-laden macrophages. Titers of several autoantibodies were elevated, and a renal biopsy revealed nephritis. The final diagnosis was mixed connective tissue disease. Macrophage iron accumulation occurs in numerous inflammatory states including autoimmune disease, cancer, and infection. Cytokines, including interleukins 6 and 22 and type I interferon, stimulate hepatic secretion of hepcidin, a peptide hormone that binds the iron exporter ferroportin and induces its degradation in macrophages and enterocytes (panel C, from Figure 1 in Andrews NC. Forging a field: the golden age of iron biology. Blood. 2008;112[2]:219-230). The net result is accumulation of iron in macrophages and impaired gut iron absorption. Consequently, iron availability for erythropoiesis is reduced, contributing to anemia of inflammation.

Advertisement intended for health care professionals